ADRC Home >> Research >> Recent Publications

UW ADRC Recent Publications
(alphabetical by author)

• Aisen PS, Berg J, Craft S, Peskind E, Thomas R. Steroid-induced hyperglycemia in Alzheimer's disease: relationship to gender, apolipoprotein E genotype, and cognition. Psychoneuroendocrinology 28:113-120, 2003.
• Allen, R. S., Burgio, L. D., Roth, D. L., Ragsdale, R., Bourgeois, M. S., Dijkstra, K., & Teri, L. The Revised Memory and Behavior Problems Checklist - Nursing Home: Instrument development and measurement of burden among nursing assistants. Psychology and Aging, 2003, 18(4), 886-895.
• Alexopoulos GS, Borson S, Cuthbert B, Devanand DP, Mulsant BH, Olin JT, Oslin DW. Assessment of late life depression. Biol Psychiatry 52:164-174, 2002.
• American Psychological Association. Guidelines for psychological practice with older adults. American Psychologist, 2004, 59, 236-260. (Guidelines drafting group: Niederehe, G. & Teri, L., co-chairs; and task force members: Duffy, M., Edelstein, B., Gallagher-Thompson, D., Gatz, M., & Hartman-Stein, G.)
• Bond, G.E., Burr, R., McCurry, S.M., Rice, M.M., Borenstein, A.R., Kukull, W.A., Teri, L., Bowen, J.D., McCormick, W.C., Larson, E.B. Alcohol, Gender, and Cognitive Performance: A Longitudinal Study Comparing Older Japanese and Non-Hispanic White Americans. Journal of Aging and Health, 2004, 16(5), 615-640.
• Bond GE, Burr RB, Rice MM, McCurry SM, Graves AB, Teri L, Larson EB. Alcohol, aging, and cognitive performance: A cross-cultural comparison. Journal of Aging and Health, 2003, 15(2), 371-390.
• Bond, G.E., Burr, R., Wolf, F M., Price, M, McCurry, S.M., Teri, L. Preliminary findings of the effects of comorbidities on a web-based intervention on self-reported blood sugar readings among adults age 60 and older with diabetes. Telemedicine and e-Health, 2006, 12(6), 707-710.
• Bonner LT, Peskind ER. Pharmacological treatments of dementia. In: The Medical Clinics of North America, in press.
• Bonner LT, Tsuang DW, Steinbart EJ, Cherrier MM, Eugenio CJ, Limprasert P, LaSpada AR, Bird TD, Seltzer B, Leverenz JB. Familial dementia with Lewy bodies with an atypical clinical presentation. Submitted.
• Bonner, L.T., Hoff, D.J., Peskind, E.R., Raskind, M.A. Prazosin reduces trauma-related nightmares in older persons with chronic posttraumatic stress disorder. Submitted.
• Borson S, Scanlan JM, Chen PJ, Ganguli M. The Mini-Cog as a screen for dementia: Validation in a population-based sample. J American Geriatrics Society, in press.
• Borson S, Scanlan JM, Doane K, Gray S. Antidepressant prescribing in nursing homes: Is there a place for tricyclic antidepressants? Int J Geriatr Psychiatry 17:1140-1145, 2002.
• Bu B, Klünemann H, Suzuki K, Li J, Bird T, Jin LW, Vincent I. Niemann-Pick Disease Type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis 11:285-297, 2002.
• Charney DS, Reynolds CF III, Lewis L, Lebowitz B, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN, Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unutzer J, Weissman MM, Young RC. National depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry, in press.
• Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto A, Peskind E, Raskind MA, Brodkin K, Bremner W, Petrova A, Latendresse S, Craft S. Testosterone improves spatial and verbal memory in healthy older men. Neurology 57:80-88, 2001.
• Cherrier, M.M., Plymate, S., Mohan, S., Asthana, S., Matsumoto, A.M., Bremner, W., Peskind, E., Raskind, M., Craft, S. Relationship between testosterone supplementatin and insulin like growth factor-I levels and cognition in healthy older men. Submitted to J Gerontol.
• Cherrier, M.M., Plymate, S., Mohan, S., Asthana, S., Matsumoto, A.M., Bremner, W., Peskind, E., Raskind, M., Craft, S. Testosterone administration increases insulin-like growth factor-I levels and cognition. Psychoneuroendocrinology (in press).
• Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin L-W, Kovacina KS, Craft S. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E (4 allele. Am J Pathology 162:313-319, 2003.
• Crane P. K., L. Jolley and G. van Belle (2003). DIFdetect (STATA software). www.alz.washington.edu/DIFdetect/welcome.html.
• Cummings, J.L., Tractenberg, R.E., Gamst, A., Teri, L., Masterman, D., Thal, L.J. Regression to the mean: Implications for clinical trials of psychotropic agents in dementia. Current Alzheimer Research, 2004, 1(4), 323-328.
• Daw EW, Wijsman EM, Thompson EA. A score for Bayesian genome screening. Gen Epidemiology, in press.
• Ding X-L, Husseman J, Tomashevski A, Nochlin D, Jin L-W, Vincent I. The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am J Pathol 157(6):1983-1989, 2000.
• Edland SD, Rieder MJ, Haji L, Swisshelm K, Martin GM, Nickerson DA, Kukull WA. Mitochondrial genetic variants and Alzheimer's disease: investigation by whole genome sequencing. Submitted.
• Edland SD, Tobe VO, Rieder MJ, Bowen JD, McCormick W, Teri L, Schellenberg GD, Larson EB, Nickerson DA, Kukull WA. Mitochondrial genetic variants and Alzheimer disease: a case-control study of the T4336C and G5460A variants. Alzheimer Dis Assoc Disord 16(1):1-7, 2002.
• Ersek, M., Turner, J., McCurry, S.M., Gibbons, L, & Kraybill, B.M. (2003). Efficacy of a self-management group intervention for elderly persons with chronic pain. Clinical Journal of Pain, 19(3), 156-67.
• Fam SS, Murphey LJ, Terry ES, Zackert WE, Chen Y, Gao L, Pandalai S, Milne GL, Roberts LJ, Porter NA, Montine TJ, Morrow JD. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-Neuroprostanes) from docosahexaenoic acid. J Biol Chem 277:36076-36084, 2002.
• Fessel J, Hulette C, Powell S, Roberts LJ, Zhang J. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. J Neurochem, in press.
• Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM. Estrogen-mediated neuroprotection against (-amyloid toxicity requires expression of estrogen receptor ( or ( and activation of the MAPK pathway. J Neurochem 82:674-682, 2002.
• George AW, Wijsman EM, Thompson EA. Detecting disease genes via a new Markov chain Monte Carlo approach for multipoint linkage analysis. Genetic Epidemology 23:283, 2002.
• Giardino ND, Borson S. COPD and depression: Incidence and treatment options. J Resp Dis 23:365-366, 2002.
• Giardino ND, Glenny R, Borson S, Chan L. Respiratory sinus arrhythmia is associated with the efficiency of pulmonary gas exchange in healthy humans. Am J Physiology: Heart and Circulatory Physiology, in press.
• Gibbons, L.E., Teri, L., Logsdon, R.G., McCurry, S.M. Assessment of anxiety in dementia: An investigation into the association of different methods of measurement. Journal of Geriatric Psychiatry and Neurology, 2006, 19(4), 202-208.
• Gibbons LE, van Belle G, Yang M, Gill C, Brayne C, Huppert FA, Paykel E, Larson E. Cross-cultural comparison of the Mini-Mental State Exam in United Kingdom and United States participants with Alzheimer's disease. Inter J Geriatric Psych 2002;17:723-8.
• Gibbons, L.E., Teri, L., Logsdon, R.G., McCurry, S.M., Kukull, W., Bowen, J.D., McCormick, W.C., Larson, E.B. Anxiety Symptoms as Predictors of Nursing Home Placement in Patients with Alzheimer's Disease. Journal of Clinical Geropsychology, 2002, 8(4), 335-342.
• Goddard KAB, Wijsman EM. Characteristics of genetic markers and maps for cost-effective genome screens using diallelic markers. Genetic Epidemiology 22:205-220, 2002.
• Hu Q, Cool BH, Wang B, Hearn MG, Martin GM. A candidate molecular mechanism for the association of an intronic polymorphism of FE65 with resistance to very late onset dementia of the Alzheimer type. Hum Mol Genet 15;11(4):465-75, 2002.
• Huse JT, Bryant B, Yang Y, Pijak DS, D'Souza I, Lah JJ, Lee VM-Y, Doms RW, Cook DG. Endoproteolysis of (-secretase (BACE) within its catalytic domain: a potential mechanism for regulation. J Biol Chem, in press.
• Husseman J, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 21(6):815-828, 2000.
• Husseman JW, Hallows JL, Bregman DB, Leverenz JB, Nochlin D, Jin L-W, Vincent I. Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol 60:1219-1222, 2001.
• Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22:1329-1333, 2002.
• Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB. Dementia and Alzheimer's disease incidence. Arch Neurol 59:1737-1746, 2002.
• Kukull, W. A. and J. D. Bowen (2002). "Dementia epidemiology." Med Clin North Am 86(3): 573-90.
• Larson, E.B., Shadlen, M.F., Wang, L., McCormick, W.C., Bowen, J.D., Teri, L., Kukull, W.A. Survival After Initial Diagnosis of Alzheimer’s Disease. Annals of Internal Medicine, 2004, 140(7), 501-509.
• Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P., Kukull, W. Exercise is associated with reduced risk of incident dementia among people aged 65 years and older. Annals of Internal Medicine, 2006, 144(2), 73-81.
• Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D, DiGiacomo L, Bowen JD, McCormick WC, Teri L, Raskind MA, Kukull WA, Larson EB. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 59(7):1099-106, 2002.
• Leverenz JB, Dobie D, Miller M, Peskind ER, Raskind MA. Increased alpha-2 adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies. Neurobiol Aging 22:555-561, 2001.
• Leverenz JB, McKeith I. Dementia with Lewy Bodies. In: The Medical Clinics of North America, in press.
• Li, G, Shofer, J.B., Kukull, W.A., Peskind, E.R., Tsuang, D.W., Breitner, J.C.S., McCormick, W., Bowen, J.D., Teri, L., Schellenberg, G.D., Larson, E.B. Serum cholesterol and risk of Alzheimer Disease: A community-based cohort study. Neurology, 2005, 65, 1045-1050.
• Li, G., Higdon, R., Kukull, W.A., Peskind, E., Moore, K.V.V., Tsuang, D., van Belle, G., McCormick, W.C., Bowen, J.D., Teri, L., Schellenberg, G.D., Larson, E.B. Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study. Neurology, 2004, 63(9), 1624-28.
• Linford NJ, Dorsa DM. 17(-estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67:1029-1040, 2002.
• Logdson, R.G., McCurry, S.M., Teri, L. Time-limited support groups for individuals with early stage dementia and their care partners: Preliminary outcomes from a controlled clinical trial. Clinical Gerontologist, 2006, 30(2), 5-13.
• Logsdon, R.G., McCurry, S.M., Teri, L. Behavioral treatment of affective disorders and associated symptoms. In: Attix, D.K., Welsh-Bohmer, K.A. (Eds.), Geriatric neuropsychology: Assessment and intervention, 2006, 349-366. New York: The Guilford Press.
• Logsdon, R.G., Teri, L., McCurry, S.M. Non-pharmacological treatment of severe dementia: The Seattle protocols. In: Burns, A., Winblad, B. (Eds.), Severe dementia, 2006, 177-183. West Sussex, England: John Wiley & Sons, Ltd.
• Logsdon, R.G., Gibbons, L.E., McCurry, S.M., Teri, L.. Assessing changes in quality of life in Alzheimer’s disease. In: Vellas, B., Grundman, M., Feldman, H., Fitten, L.J., Winblad, B., Giacobini, E. (Eds.) Research and practice in Alzheimer’s disease and cognitive decline, 2005, Volume 10, pp. 221-225. New York: Springer Publications.
• Logsdon, R.G., McCurry, S.M., Teri, L. A home health care approach to exercise for persons with Alzheimer's disease. Care Management Journals. 2005, 6(2), 90-97.
• Logsdon, R.G., McCurry, S.M., Teri, L. STAR-Caregivers: A community-based approach for teaching family caregivers to use behavioral strategies to reduce affective disturbances in persons with dementia. Alzheimer's Care Quarterly, 2005, 6(2), 146-153.
• Logsdon, R.G., Gibbons, L.E., McCurry, S.M. & Teri, L. (1999). Quality of life in Alzheimer’s disease: Patient and caregiver reports. Journal of Mental Health and Aging, 1999, 5(1), 21-32.
• Logsdon, R.G. (2002). Making the most of every day: Quality of life in Alzheimer's disease. In P.B. Harris (Ed.) The Person with Alzheimer's Disease: Pathways to Understanding the Experience. Baltimore: Johns Hopkins Press, pp. 75-87.
• Logsdon, R.G., Gibbons, L.E., McCurry, S.M., & Teri, L. Assessing quality of life in older adults with cognitive impairment. Psychosomatic Medicine, 2002, 64(3), 510-519.
• Logsdon, RG (2002). Increasing Pleasant Events. Article in Northwest Caregiver Newsletter, published by Legacy Community Health Education Services, Portland, OR, Summer/Autumn, 2002, 2-3.
• Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 47(8):723-733, 2002.
• McCormick, W.C., Ohata, C.Y., Uomoto, J., Young, H., Graves, A.B., Kukull, W., Teri, L., Vitaliano, P., Mortimer, J.A., McCurry, S.M., Bowen, J., & Larson, E.B. Similarities and differences in attitudes toward long term care between Japanese Americans and Caucasian Americans. Journal of the American Geriatrics Society. 2002, 50(6), 1149-55.
• McCurry, S.M., Logsdon, R.G., Teri, L., Vitiello, M.V. Sleep disturbances in caregivers of persons with dementia: Contributing factors and treatment implications. Sleep Medicine Reviews, 2007, 11, 143-153.
• McCurry, S.M., Logsdon, R.G., Gibbons, L.E., Vitiello, M.V., Teri, L. Behavioral treatment for sleep disturbances in Alzheimer's disease: The NITE-AD study. In: Vellas, B., Fitten, L.J., Winblad, B., Feldman, H., Grundman, M., Giacobini, E. (Eds.), Research and practice in Alzheimer's disease, 2006, Volume 11, pp. 341-346. New York: Springer Publications
• McCurry, S.M., Vitiello, M.V., Gibbons, L.E., Logsdon, R.G., Teri, L. Factors associated with caregiver reports of sleep disturbances in persons with dementia. American Journal of Geriatric Psychiatry, 2006, 14(2), 112-120.
• McCurry, S.M., Gibbons, L.E., Logsdon, R.G., Vitiello, M.V., & Teri, L. Nighttime insomnia treatment and education for Alzheimer’s disease: A randomized controlled trial, Journal of American Geriatric Society, 2005, 53(5), 793-802.
• McCurry, S.M., Gibbons, L.E., Logsdon, R.G., & Teri, L. Anxiety and nighttime behavioral disturbances: Awakenings in patients with Alzheimer's disease. Journal of Gerontological Nursing, 2004, 30(1), 12-20.
• McCurry, S.M., Logsdon, R.G., Vitiello, M.V., Teri, L. Treatment of sleep and nighttime disturbances in Alzheimer’s disease: A behavior management approach. Sleep Medicine, 2004, 5(4), 373-7.
• McCurry SM, Gibbons LE, Uomoto JM, Thompson ML, Graves AB, Edland SD, Bowen J, McCormick WC, Larson EB. Neuropsychological test performance in a cognitively intact sample of older Japanese American adults. Archives of Clin Neuropsychology 2001;16:447-459.
• McCurry, S.M. & Ancoli-Israel, S. (2003). Sleep dysfunction in AD and other dementias. Current Treatment Options in Neurology, 5(3), 261-272.
• McCurry, S.M., Gibbons, L.E., Bond, G., Rice, M.M., Graves, A.B., Kukull, W., Teri, L., Higdon, R., Bowen, J.E., McCormick, W.C., Larson, E.B. Older adults and functional decline: A cross-cultural comparison. International Psychogeriatrics, 2002, 14(2), 161-179.
• McCurry, S.M., Logsdon, R.G., Vitiello, M.V., Gibbons, L.E., & Teri, L. Training caregivers to change the sleep practices of patients with dementia: The NITE-AD study. Journal of the American Geriatrics Society, 2003, 51(10), 1455-1460.
• Meeks, S., Teri, L., Van Haitsma, K., Looney, S. Increasing pleasant events in the nursing home: Collaborative behavioral treatment for depression. Clinical Case Studies, 2006, 5(4), 287-304.
• Milatovic D, Zhang Y, Olson SJ, Montine KS, Roberts LJ, Morrow JD, Montine TJ, Dermody TS, Valyi-Nagy T. Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. J Neurovirol 8:295-305, 2002.
• Mize AL, Sharpiro RA, Dorsa DM. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144:306-312, 2003.
• Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ, Kaye J, Morrow JD. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in patients with Alzheimer's disease or in an animal model of cerebral oxidative damage. Ann Neurol 52:175-179, 2002.
• Musiek ES, Cha JK, Yin H, Zackert WE, Terry ES, Porter NA, Montine TJ, Morrow JD. Quantification of F-ring isoprostane-like compounds (F4-Neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J Bio Chem, in press
• Peskind ER, Griffin ST, Akama KT, Raskind MA, Van Eldik LJ. Cerebrospinal fluid S100? is elevated in the earlier stages of Alzheimer's disease. Neurochem Int 39:409-413, 2001
• Peskind ER, Wilkinson CW, Petrie E, Schellenberg G, Raskind MA. Increased cerebrospinal fluid cortisol in Alzheimer's disease is a function of apolipoprotein E genotype. Neurology 56:1094-1098, 2001.
• Peskind, E.R., Tsuang, D.W., Bonner, L.T., Pascualy, M., Riekse, R.G., Snowden, M.B., Thomas, R., Raskind, M.A. Propranolol augmentation reduces agitation and anxiety in nursing home residents with Alzheimer's disease. Submitted.
• Petrie EC, Peskind ER, Dobie DJ, Veith RC, Raskind MA. Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging. Psychoneuroendocrinology 26:147-164, 2001.
• Phillips, L.E., T.D. Koepsell, G. van Belle, W.A. Kukull, J.A. Gehrels, W.T. Longstreth (2002). History of head trauma and risk of intracranial meningioma: Population-based case-control study. Neurology, 58: 1849-1852.
• Poorkaj P, Muma NA, Zhukareva V, Cochran EJ, Shannon KM, Hurtig H, Koller WC, Bird TD, Trojanowski JQ, Lee VM-Y, Schellenberg GD. An R5L ( mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol 52:511-516, 2002.
• Raskind MA, Peskind ER. Alzheimer's Disease and Related Disorders. In: The Medical Clinics of North America. Advances in the Pathophysiology and Treatment of Psychiatric Disorders: Implications for Internal Medicine, CB Nemeroff (ed.) Philadelphia, W.B. Saunders, pp. 803-817, 2001.
• Raskind MA, Peskind ER. Treatment of Noncognitive Symptoms in Alzheimer's Disease and Other Dementias. In: American Psychiatric Press Textbook of Psychopharmacology (2nd ed.), AF Schatzberg, CB Nemeroff (eds.). Washington, DC, American Psychiatric Press, pp. 447-455, 2001.
• Raskind, M.A., Bonner LT, Peskind, E.R. Cognitive Disorders. In: Textbook of Geriatric Psychiatry, E.W. Busse, D.G. Blazer (eds). Washington, D.C., American Psychiatric Press, (in press).
• Raskind, M.A., Peskind, E.R., Truyen, L., Kershaw, P., Damaraju, C.V. The cognitive benefits of galantamine are sustained for at least 36 months: A long-term extension trial. Submitted to Archives of Neurology (1/03).
• Raskind, M.A., Wilkinson, C.W., Peskind, E.R. Aging and Alzheimer's Disease. In: Hormones, Brain, and Behavior, Volume 5. D.W. Pfaff, A.P. Arnold, A.M. Etgen, S.E. Fahrbach, R.T. Rubin (eds.). San Diego, Academic Press, CA, pp 637-664, 2002.
• Riekse, R.G., Leverenz, J.B., McCormick, W.C., Bowen, J.D., Teri, L., Nochlin, D., Simpson, K., Eugenio, C., Larson, E.B., Tsuang, D. Effect of Vascular Lesions on Cognition in Alzheimer’s Disease: A Community-based Study. Journal of the American Geriatrics Society, 2004, 52(9), 1442-1448.
• Rosin RA, Levine MD, Peskind ER. Transdermal nicotine for treatment-resistant agitation in dementia. Am J Geriatr Psychiatry, in press.
• Royall D, Borson S. Geriatric depression and chronic medical disease: Another world of hurt (Editorial). JAGS 50(5):969, 2002.
• Scanlan J, Brush M, Quijano C, Borson S. Comparing clock tests for dementia screening: Naďve judgments vs. formal systems-what is optimal? Int J Geriatr Psychiatry 17(1):14-21, 2002.
• Scanlan JM, Vitaliano PP, Zhang J, Savage M, Ochs HD. Lymphocyte proliferation is associated with gender, anger, and depressed mood in older adults. J Behav Medicine 24:537-559, 2001.
• Schaie, W.K., Caskie, G.I., Revell, A.J., Willis, S.L., Kaszniak, A.W., Teri, L. Extending neuropsychological assessments into the primary mental ability space. Aging, Neuropsychology, and Cognition, 2005, 12(3), 245-277. need pdf
• Shadlen, M.F., Larson, E.B., Wang, L., Phelan, E.A., McCormick, W.C., Jolley, L., Teri, L., van Belle, G. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline. Neurobiology of Aging , 2005, 26(1), 17-24.
• Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 25:13(4):455-9, 2002.
• Stockbridge, H.L., D. Lewis, M. Eisenberg, M. Lee, S. Schachter, G. van Belle, M. Keifer, C.A. Brodkin, and D. Buchwald (2002). Brain SPECT: a controlled, blinded assessment of intra-reader and inter-reader agreement. Nuclear Medicine Communications, 23: 537-544.
• Szot, P., Wilkinson, C.W., White, S., Leverenz, J.B., Greenup, J.L., Colasurdo, E.A., Peskind, E.R., Raskind, M.A. Hypercortisolemia of Alzheimer's disease and chronic glucocorticoid treatment of nonhuman primates differentially affect pituitary and hypothalamic peptide message expression. Submitted to J Neuroscience (8/02).
• Teri, L., Huda, P., Gibbons, L. A., Young, H., & van Leynseele, J. STAR: A dementia-specific training program for staff in assisted living residences. The Gerontologist, 2005, 45(5), 686-693.
• Teri, L., Logsdon, R.G., & McCurry, S.M. The Seattle protocols: Advances in behavioral treatment of Alzheimer’s disease. In: Vellas, B., Grundman, M., Feldman, H., Fitten, L.J., Winblad, B., Giacobini, E. (Eds.), Research and practice in Alzheimer’s disease and cognitive decline, 2005, 10, 153-158. New York: Springer Publications.
• Teri, L., McCurry, S.M., Logsdon, R.G., Gibbons, L.E. Training community consultants to help family members improve dementia care: A randomized controlled trial. The Gerontologist, 2005, 45(6), 802-11.
• Teri, L., McKenzie, G., LaFazia. Psychosocial treatment of depression in older adults with dementia. Clinical Psychology: Science and Practice, 2005, 12(3), 303-316.
• Teri, L. Gibbons, L.E., McCurry, S.M., Logsdon, R.G., Buchner, D.M., Barlow, W.E., Kukull, W.A., LaCroix, A.Z., McCormick, W.C., Larson, E.B. Exercise Plus Behavioral Management in Patients with Alzheimer Disease: A Randomized Controlled Trial. JAMA, 2003, 290(15), 2015-2022.
• Teri L, Logsdon RG, Peskind E, Raskind M, Weiner M, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus APA, Grundman M, Thomas RG, Schafer K, Thal LJ. Treatment of agitation in Alzheimer's disease: An investigation of haloperidol, trazodone and behavior management techniques. Research and Practice in Alzheimer's Disease and other Dementias 5:27-31, 2001.
• Teri, L., Logsdon, R.G., Whall, A.L., Weiner, M.F., Trimmer, C., Peskind, E., Thal, L., & members of the Alzheimer’s Disease Cooperative Study. Treatment for agitation in dementia patients: A behavioral management approach. Psychotherapy, 1998, 35(4), 436–443.
• Teri, L., Logsdon, R.G., McCurry, S.M. Nonpharmacological Treatment of Behavioral Disturbances in Dementia, Medical Clinics of North America: Special Issue on Dementia, 2002, 86(3), 641-656.
• Tomashevski A, Husseman J, Jin L-W, Nochlin D, Vincent I. Constitutive Wee 1 activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration. J Alz Dis 3(2):195-207, 2001.
• Tractenberg, R.E., Weiner, M.F., Patterson, M.B., Teri, L., Thal, L.J. Comorbidity of Psychopathological Domains in Community-dwelling persons with Alzheimer’s Disease. Journal of Geriatric Psychiatry and Neurology, 2003, 16(2), 94-99.
• Tsuang, D., Simpson, K., Li, G., Barnhart, R., Edland, S., Bowen, J., McCormick, W., Teri, L., Nochlin, D., Larson, E., Thompson, M., Leverenz, J. Evaluation of selection bias in an incident-based dementia autopsy case series. Alzheimer Disease & Associated Disorders, 2005, 19(2), 67-73.
• Tsuang D, Bird TD. Genetics of dementia. In: Comprehensive Review of Geriatric Psychiatry, Third Edition. American Psychiatric Press, Inc., in press.
• Tsuang D, Bird TD. Genetics of dementia. Medical Clinics of North America. 86:591-614,2002.
• Tsuang DW, Dalan AM, Eugenio CJ, Steinbart EJ, Bird TD, Leverenz JB. Familial Dementia with Lewy Bodies: A Clinico-neuropathological Study of Two Families. Arch Neurol 59:1622-1630, 2002.
• van Belle, G. (2002). Statistical Rules of Thumb. John Wiley and Sons, New York, NY
• Vincent I, Bu B, Tomashevski A, Husseman J, Nochlin D, Jim L-W. Constitutive Cdc25B activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration. Neuroscience 105(3):639-650.
• Vincent I. Cycling to the finish (editorial). Neurobiol Aging 21(6):757-760, 2000.
• Vuletic, S., Jin, L-W., Marcovina, S.M., Peskind, E.R., Albers, J.J. Regional differences in PLTP mRNA and protein in human brain. J Lipid Research (in revision).
• Wade CB, Dorsa DM. Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144:832-838, 2003.
• Wang, L., G. van Belle, W. B. Kukull and E. B. Larson (2002). "Predictors of functional change: a longitudinal study of non-demented elderly aged 65 or older." J Am Geriatr Soc 50(9): 1525-1534.
• Watson, G.S., Peskind, E.R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Farris, W., Selkoe, D.J., Schwartz, M.W., Schellenberg, G.D., Plymate, S., Craft, S. Insulin increases A?42 levels in normal adults. Submitted.
• Weiner, M.F., Teri, L. Psychological and Behavioral Management. In: M.F. Weiner & A.M. Lipton, (Eds.), Dementias: Diagnosis and Treatment Research, 3rd Edition, Washington, DC: American Psychiatric Publishing, Inc, 2003, 181-218.
• Weiner, M.F., Tractenberg, R.E., Sano, M., Logsdon, R.G., Teri, L., Galasko, D. Gamst, A., Thomas, R., & Thal, L.J. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. Journal of Geriatric Psychiatry and Neurology. 2002, 15(2), 95-8.
• Wilkinson CW, Petrie EC, Murray S, Colasurdo EA, Raskind MA, Peskind ER. Human glucocorticoid feedback inhibition is reduced in older individuals: Evening study. J Clin Endocrinol Metab 85:545-550, 2001.
• Wolkowitz, O.M., Kramer, J.H., Reus, V.L., Costa, M.M., Yaffe, K., Walton, P., Raskind, M., Peskind, E., Newhouse, P., Sack, D., DeSouza, E., Sadowsky, C., Roberts, E., and the DHEA Alzheimer's Disease Collaborative Research Group. DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled pilot study. Neurology (in press).
• Xu J, Kao S-Y, Lee FJ, Song W, Jin L-W, Yankner BA. Dopamine-dependent neurotoxicity of native a-synuclein: a mechanism for selective neurodegeneration in Parkinson's disease. Nature Medicine 8:600-606, 2002.
• Zareparsi S, James DM, Kaye JA, Bird TD, Schellenberg GD, Payami H. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology 26:58(6):973-5, 2002.

| ADRC HOME | About the ADRC | Studies | DIMENSIONS | Research |
| Community Resources | Health Care Resources | Resouces for Researchers & Clinicians | Training and Educational Resources |

adrcweb@u.washington.edu
UW ADRC Core B: Education and Training--Linda Teri, Ph.D., Director
Last Modified: Friday, 04-May-2007 16:49:46 PDT